Your browser doesn't support javascript.
loading
Dual time point method for the quantification of irreversible tracer kinetics: A reference tissue approach applied to [18F]-FDOPA brain PET.
Lopes Alves, I; Meles, Sanne K; Willemsen, Antoon Tm; Dierckx, Rudi A; Marques da Silva, Ana M; Leenders, Klaus L; Koole, Michel.
Afiliación
  • Lopes Alves I; 1 Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, The Netherlands.
  • Meles SK; 2 Department of Neurology, University of Groningen, University Medical Center Groningen, the Netherlands.
  • Willemsen AT; 1 Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, The Netherlands.
  • Dierckx RA; 1 Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, The Netherlands.
  • Marques da Silva AM; 3 Laboratory of Medical Imaging, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
  • Leenders KL; 2 Department of Neurology, University of Groningen, University Medical Center Groningen, the Netherlands.
  • Koole M; 4 Department of Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium.
J Cereb Blood Flow Metab ; 37(9): 3124-3134, 2017 09.
Article en En | MEDLINE | ID: mdl-28156211
The Patlak graphical analysis (PGAREF) for quantification of irreversible tracer binding with a reference tissue model was approximated by a dual time point imaging approach (DTPREF). The DTPREF was applied to 18 [18F]-FDOPA brain scans using the occipital cortex as reference region (DTPOCC) and compared to both PGAOCC and striatal-to-occipital ratios (SOR). Pearson correlation analysis and Bland-Altman plots showed an excellent correlation and good agreement between DTPOCC and PGAOCC, while correlations between SOR and PGAOCC were consistently lower. Linear discriminant analysis (LDA) demonstrated a similar performance for all methods in differentiating patients with Parkinson's disease (PD) from healthy controls (HC). Specifically for [18F]-FDOPA brain imaging, these findings validate DTPOCC as an approximation for PGAOCC, providing the same quantitative information while reducing the acquisition time to two short static scans. For PD patients, this approach can greatly improve patient comfort while reducing motion artifacts and increasing image quality. In general, DTPREF can improve the clinical applicability of tracers with irreversible binding characteristics when a reference tissue is available.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Procesamiento de Imagen Asistido por Computador / Encéfalo / Dihidroxifenilalanina / Tomografía de Emisión de Positrones / Modelos Teóricos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Cereb Blood Flow Metab Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Procesamiento de Imagen Asistido por Computador / Encéfalo / Dihidroxifenilalanina / Tomografía de Emisión de Positrones / Modelos Teóricos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Cereb Blood Flow Metab Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos